Monib Zirvi Ph.D. ’96 M.D. ’00 on Jan. 23 filed a petition asking the high court to review his malpractice claim alleging that Akin Gump, a prominent law firm who represented Cornell in litigation ...
4don MSN
Sequencing work at San Diego’s Frozen Zoo expected to ‘dramatically expand’ science of conservation
For 50 years, scientists at the San Diego Zoo have been collecting and storing cells from rare and endangered species in its Frozen Zoo with an eye to the future. The future is here. The San Diego Zoo ...
Illumina Inc. (Nasdaq: ILMN), a genomics and molecular diagnostics company headquartered in San Diego, closed in late January on its acquisition of Boulder-based biotech firm SomaLogic Inc.
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease ...
Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...
"The fourth quarter confirmed the positive earnings trend that we have seen throughout the year. Operating profit amounted to SEK 18.0 million (-3.7) for the quarter and to SEK 10.1 million (-62.3) fo ...
The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...
The fund underperformed the MSCI ACWI ex-US Growth Index but outperformed the Morningstar Foreign Large Growth peer group ...
At a time when it was assumed that there would be flying cars and sentient artificial intelligence robots living among humans, South Africa is slowly but surely asserting itself in science, ...
The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Despite currency headwinds and margin challenges, Devyser Diagnostics AB (FRA:OL0) achieves significant revenue growth and strategic market positioning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results